ChEMBL ID: CHEMBL2109389
Mechanism of action: Epidermal growth factor receptor erbB1 antagonist
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to IMGATUZUMAB